Finance

Lists
Q3 2026 earnings • 6:00 PM today
See details
CLN:WSE
Celon Pharma SA
15,50 PLN
+0,65%
(+0,10) 1D
18 ნოე, 17:00:00 GMT+1  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
15,34 PLN
High
15,86 PLN
Low
15,30 PLN
Mkt. cap
835,63 მლნ.
Avg. vol.
30,56 ათ.
Volume
34,75 ათ.
P/E ratio
7,55
52-wk high
23,50 PLN
52-wk low
15,20 PLN
EPS
2,05 PLN
Shares outstanding
53,91 მლნ.
No. of employees
560
Open
15,34 PLN
High
15,86 PLN
Low
15,30 PLN
Mkt. cap
835,63 მლნ.
Avg. vol.
30,56 ათ.
Volume
34,75 ათ.
P/E ratio
7,55
52-wk high
23,50 PLN
52-wk low
15,20 PLN
EPS
2,05 PLN
Shares outstanding
53,91 მლნ.
No. of employees
560
News stories
From web sources and news partners
24/7 Wall St.
24/7 Wall St.
·
1 საათის წინ
S&P 500 Slides 0.6% at Midday as the Dow Drops Over 1%
TradingView
TradingView
·
2 საათის წინ
S&P 500, Nasdaq find footing as Nvidia treads water
ChartMill
ChartMill
·
2 საათის წინ
S&P 500 Gap-Down Movers for Nov. 18 Session
JournalArta
JournalArta
·
1 საათის წინ
S&P 500 Futures Rise After Nvidia Raises Sales Forecast
About Celon Pharma SA
CEO-
Employees560
Founded2002
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Awaiting results...
Call Time: Today, 18:00
Fiscal period
Q3 2026
- / -
Revenue / Est. (PLN)
- / 63,50 მლნ.
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
71,13 მლნ.
66,67 მლნ.
65,26 მლნ.
55,57 მლნ.
Cost of goods sold
16,83 მლნ.
11,54 მლნ.
16,70 მლნ.
14,92 მლნ.
Cost of revenue
16,83 მლნ.
11,54 მლნ.
16,70 მლნ.
14,92 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33,02 მლნ.
35,44 მლნ.
36,08 მლნ.
38,62 მლნ.
Operating expense
46,24 მლნ.
52,60 მლნ.
54,54 მლნ.
50,11 მლნ.
Total operating expenses
63,07 მლნ.
64,14 მლნ.
71,23 მლნ.
65,04 მლნ.
Operating income
8,06 მლნ.
2,53 მლნ.
-5,98 მლნ.
-9,46 მლნ.
Other non operating income
-30,00 ათ.
-250,00 ათ.
169,05 მლნ.
3,48 მლნ.
EBT including unusual items
-2,77 მლნ.
-6,57 მლნ.
160,34 მლნ.
-7,38 მლნ.
EBT excluding unusual items
-2,77 მლნ.
-6,57 მლნ.
160,34 მლნ.
-7,38 მლნ.
Income tax expense
-6,43 მლნ.
18,33 მლნ.
1,70 მლნ.
23,21 მლნ.
Effective tax rate
232,29%
-279,14%
1,06%
-314,48%
Other operating expenses
2,20 მლნ.
6,37 მლნ.
7,33 მლნ.
1,36 მლნ.
Net income
3,66 მლნ.
-24,90 მლნ.
158,64 მლნ.
-30,59 მლნ.
Net profit margin
5,15%
-37,35%
243,09%
-55,05%
Earnings per share
-
-
-
-
Interest and investment income
-
149,00 ათ.
151,00 ათ.
151,00 ათ.
Interest expense
-
-341,00 ათ.
-915,00 ათ.
-1,55 მლნ.
Net interest expenses
-
-192,00 ათ.
-764,00 ათ.
-1,40 მლნ.
Depreciation and amortization charges
11,01 მლნ.
10,78 მლნ.
11,13 მლნ.
10,13 მლნ.
EBITDA
16,34 მლნ.
11,40 მლნ.
3,44 მლნ.
-748,00 ათ.
Gain or loss from assets sale
-170,00 ათ.
-2,91 მლნ.
-569,00 ათ.
716,00 ათ.
Upcoming events
AI content may include mistakes. Learn more
Google აპები